Friday, April 26, 2024
4/26/2024
Protein aggregation and mitochondrial dysfunction are key factors in aging and in neurodegenerative disease, like Alzheimer’s disease. It is clear that full understanding of mechanisms that neurons employ to combat these toxic threats will be critical for development of clinical neuroprotective strategies. The Driscoll lab has found that C. elegans neurons can sort and throw out neuronal debris for remote degradation in a novel “extracellular garbage elimination” strategy. We call such extrusions, which are large ~.4um membrane-surrounded vesicles that can include protein aggregates and mitochondria, “exophers”. We speculate that trash expulsion complements known intracellular protein and organelle degradation pathways to help maintain homeostasis. Consistent with this idea, neurons that extrude aggregate-filled exophers maintain better functionality than neurons that did not produce exophers. We also speculate that the mechanism of aggregate/mitochondrial hand-off to neighboring cells might constitute a conserved process relevant to the spread of pathological materials in mammalian neurodegenerative disease. Advancing understanding of the newly discovered exopher biology is thus likely to be of high impact in the neuroscience field. My interests is focused on deciphering why and how mitochondria are selected for expulsion in exophers. Data suggest that dysfunctional mitochondria may be preferentially extruded, but understanding of the conditions for segregation of particular mitochondria into the exopher compartment, and the cellular machinery that mediates this distinction is in its infancy. I will utilize the powerful molecular genetic tools of C. elegans to investigate principal mechanisms that mark, move, and expel mitochondria within exophers. My first aim is to define conditions that induce production of mitochondrial exophers and verify that mitochondria are of poor health under such conditions. I will use genetic means to test a range of mitochondrially-focused damage (heteroplasmy, cristae disruption, quality control impairment) to reveal the types of mitochondrial dysfunction that provoke extrusion for remote degradation. I will also investigate the details by which mitochondrial superoxide elevation increases the production of mito-exophers using genetics, optogenetics tools, mitochondrial assessment tools and high resolution microscopy. My second aim is to identify genes that are required for mitochondrial exopher production. I will use RNAi approaches to test candidate gene sets (including some uniquely available to us based on proteomics of candidate mammalian mitochondrial-loaded exophers). Time permitting, I will also participate in an unbiased screen for genes that can modulate production of exophers. I will initiate a detailed mechanistic study of 1-2 conserved genes to contribute some of the first molecular understanding of the exopher-genesis pathway. Given the profound importance of mitochondria in all of biology, especially in neurodegenerative disease and aging, the work I plan should be significant in carving out a new research area highly relevant to human health.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
